Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
LOS ANGELES, June 12, 2017 (GLOBE NEWSWIRE) -- JLT Specialty USA, a U.S. subsidiary of Jardine Lloyd Thompson Group plc. (LSE:JLT), one of the world’s leading specialty-focused providers of...
-
Atlanta, GA, June 12, 2017 (GLOBE NEWSWIRE) -- Atlanta, Georgia – June 12, 2017 Spiralogics, Inc. a leading IT firm out of Atlanta today announced it will be expanding its product line with the...
-
SAN MATEO, Calif., June 12, 2017 (GLOBE NEWSWIRE) -- EverString, the leader in AI-assisted sales and marketing software, today announced its partnership with Bombora, the leading provider of B2B...
-
HENDERSON, Nev., June 12, 2017 (GLOBE NEWSWIRE) -- Delivering on its promise to design homes that are not only compelling to Millennials but that can be appreciated by anyone with an eye for modern...
-
REDWOOD CITY, Calif., June 12, 2017 (GLOBE NEWSWIRE) -- According to a recent report by Dell’Oro Group, the trusted source for information about the telecommunications, networks, and data center IT...
-
SILICON VALLEY, Calif., June 12, 2017 (GLOBE NEWSWIRE) -- Proxim Wireless Corporation (OTC Markets:PRXM), a pioneer and global leader in point to point (PtP) and point to multipoint (PtMP) fixed and...
-
ALBUQUERQUE, NM and SAN DIEGO, CA, June 12, 2017 (GLOBE NEWSWIRE) -- Exagen Diagnostics, Inc., home of AVISE® testing, announced the nationwide availability of a new test leveraging the power of...
-
Interim Analyses for Key FOCUS Study Expected in August 2017 and September 2017Investigator-Sponsor Pauses Enrollment in PAZOFOS Study in U.K. SOUTH SAN FRANCISCO, Calif., June 12, 2017 (GLOBE...
-
BEDMINSTER, N.J. and DUBLIN, Ireland, June 12, 2017 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN), a biopharmaceutical company focused on the commercialization and development of...
-
REDWOOD CITY, Calif., June 12, 2017 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (NASDAQ:CHRS), today announced that the U.S. Food and Drug Administration (“FDA”) has issued a complete response...